Argus Downgrades Moderna (MRNA) to Hold
Tweet Send to a Friend
(Updated - December 18, 2024 8:31 AM EST)
Argus analyst John Eade downgraded Moderna (NASDAQ: MRNA) from Buy to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Argus analyst John Eade downgraded Moderna (NASDAQ: MRNA) from Buy to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
